Breakthrough in treatment for Dupuytren’s disease

Breakthrough in treatment for Dupuytren’s disease

Researchers at the Kennedy Institute, University of Oxford, led by Professor Jagdeep Nanchahal have demonstrated the efficacy of the anti-TNF drug adalimumab for patients with early stage Dupuytren’s disease.

Comments are closed.

An algorithm that screens for child neglect raises concerns
29 April 2022
Virus might be behind mystery child hepatitis cases: US agency
30 April 2022